VERTEX PHARMACEUTICALS INC / MA — Director's Dealing 2020

Jan 10, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: VERTEX PHARMACEUTICALS INC / MA (VRTX)
CIK: 0000875320
Period of Report: 2020-01-08

Reporting Person: Sachdev Amit (EVP, Chief Patient Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-01-08	Common Stock	M	5000	$109.14	Acquired	41190	Direct
2020-01-08	Common Stock	S	5000	$230.00	Disposed	36190	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-01-08	Stock Option (Right to Buy)	$109.14	M	5000	Disposed	2025-02-02	Common Stock (5000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	882	Indirect
Common Stock	16190	Indirect

Footnotes

F1: Transaction made pursuant to Mr. Sachdev's company-approved trading plan under Rule 10b5-1.

F2: Reflects changes in the form of ownership resulting from transfers of shares between trusts and Mr. Sachdev.

F3: Fully vested.